Jazz Pharmaceuticals Plc Stock Fundamentals
Jazz Pharmaceuticals PLC fundamentals help investors to digest information that contributes to Jazz Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Jazz Stock. The fundamental analysis module provides a way to measure Jazz Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Jazz Pharmaceuticals stock.
Jazz |
Jazz Pharmaceuticals PLC Company Return On Asset Analysis
Jazz Pharmaceuticals' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Jazz Pharmaceuticals Return On Asset | 0.0407 |
Most of Jazz Pharmaceuticals' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jazz Pharmaceuticals PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Jazz Pharmaceuticals PLC has a Return On Asset of 0.0407. This is 100.47% lower than that of the Pharmaceuticals sector and 100.17% lower than that of the Health Care industry. The return on asset for all United States stocks is 129.07% lower than that of the firm.
Jazz Pharmaceuticals PLC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Jazz Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Jazz Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Jazz Pharmaceuticals competition to find correlations between indicators driving Jazz Pharmaceuticals's intrinsic value. More Info.Jazz Pharmaceuticals PLC is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies reporting about 0.43 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Jazz Pharmaceuticals PLC is roughly 2.31 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Jazz Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Jazz Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Jazz Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Jazz Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jazz Pharmaceuticals' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jazz Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Jazz Pharmaceuticals by comparing valuation metrics of similar companies.Jazz Pharmaceuticals is currently under evaluation in return on asset category among related companies.
Jazz Fundamentals
| Return On Equity | 0.0941 | ||||
| Return On Asset | 0.0407 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 10.87 B | ||||
| Shares Outstanding | 63.04 M | ||||
| Shares Owned By Insiders | 2.77 % | ||||
| Shares Owned By Institutions | 97.15 % | ||||
| Number Of Shares Shorted | 3.6 M | ||||
| Price To Earning | 35.18 X | ||||
| Price To Book | 1.84 X | ||||
| Price To Sales | 1.80 X | ||||
| Revenue | 3.83 B | ||||
| Gross Profit | 3.39 B | ||||
| EBITDA | 1.3 B | ||||
| Net Income | 414.83 M | ||||
| Cash And Equivalents | 899.36 M | ||||
| Cash Per Share | 14.28 X | ||||
| Total Debt | 5.8 B | ||||
| Debt To Equity | 2.12 % | ||||
| Current Ratio | 3.16 X | ||||
| Book Value Per Share | 58.65 X | ||||
| Cash Flow From Operations | 1.09 B | ||||
| Short Ratio | 6.62 X | ||||
| Earnings Per Share | 4.83 X | ||||
| Price To Earnings To Growth | 0.84 X | ||||
| Target Price | 181.24 | ||||
| Number Of Employees | 2.8 K | ||||
| Beta | 0.63 | ||||
| Market Capitalization | 6.91 B | ||||
| Total Asset | 11.39 B | ||||
| Retained Earnings | 878.66 M | ||||
| Working Capital | 1.9 B | ||||
| Current Asset | 1.26 B | ||||
| Current Liabilities | 226.64 M | ||||
| Net Asset | 11.39 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Jazz Pharmaceuticals PLC information on this page should be used as a complementary analysis to other Jazz Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Tools for Jazz Stock
When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |